The aim of this study was to establish the long-term safety and efficacy of a sirolimus-eluting stent with bioresorbable polymer (BP-SES; Ultimaster) by comparison with an everolimus-eluting stent with permanent polymer (PP-EES; XIENCE).
Long-term clinical outcomes after bioresorbable and permanent polymer drug-eluting stent implantation: final five-year results of the CENTURY II randomised clinical trial / Wijns, William; Valdes-Chavarri, Mariano; Richardt, Gert; Moreno, Raul; Íñiguez-Romo, Andrés; Barbato, Emanuele; Carrié, Didier; Ando, Kenji; Merkely, Béla; Kornowski, Ran; Eltchaninoff, Hélène; Stojkovic, Sinisa; Saito, Shigeru. - In: EUROINTERVENTION. - ISSN 1969-6213. - 14:3(2018), p. e343-e351. [10.4244/EIJ-D-18-00358]
Long-term clinical outcomes after bioresorbable and permanent polymer drug-eluting stent implantation: final five-year results of the CENTURY II randomised clinical trial
Barbato, EmanueleMembro del Collaboration Group
;
2018
Abstract
The aim of this study was to establish the long-term safety and efficacy of a sirolimus-eluting stent with bioresorbable polymer (BP-SES; Ultimaster) by comparison with an everolimus-eluting stent with permanent polymer (PP-EES; XIENCE).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
